Prescription of EPs 7630 is associated with short- and long-term benefits in acute bronchitis: a real-world data analysis.
Saved in:
| Title: | Prescription of EPs 7630 is associated with short- and long-term benefits in acute bronchitis: a real-world data analysis. |
|---|---|
| Authors: | Gillissen A; Department of Pulmonary and Intensive Care Medicine, Klinikum Stuttgart, Katharinenhospital, Stuttgart, Germany., Reineke T; Research and Development, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany., Burkart M; Global Medical Affairs, Dr. Schwabe Holding SE & Co. KG, Karlsruhe, Germany., Funk P; Research and Development, Dr. Willmar Schwabe GmbH & Co. KG, Karlsruhe, Germany., Adarkwah CC; Institute of General Practice, Philipps-University Marburg, Marburg, Germany., Kostev K; Epidemiology, IQVIA, Frankfurt a. M., Germany. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 Sep 15; Vol. 16, pp. 1652203. Date of Electronic Publication: 2025 Sep 15 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2025.1652203 |
